Showing results (681-690 of 1,919) with videos related to
Sort By:
Pageof 192
Cancer Biomarkers : Section a of Disease Markers|July 28, 2020
Identification of diagnostic and prognostic lncRNA biomarkers in oral squamous carcinoma by integrated analysis and machine learningSen Yang, Yingshu Wang, Jun Ren, et al.Cancer Biomarkers : Section a of Disease Markers|July 28, 2020
MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting FOXO1 and activating PI3K/AKT pathwayLin Zhu, Yinan Chen, Jing Liu, et al.Cancer Biomarkers : Section a of Disease Markers|April 12, 2021
SPARC regulates ferroptosis induced by sorafenib in human hepatocellular carcinomaHong-Wei Hua, Hao-Sheng Jiang, Ling Jia, et al.Cancer Biomarkers : Section a of Disease Markers|August 4, 2020
TGF-β downregulation overcomes gemcitabine resistance in oral squamous cell carcinomaYun-Ze Xuan, Cheng-Ri Jin, Kang-Juan YangCancer Biomarkers : Section a of Disease Markers|August 25, 2020
A fourteen-lncRNA risk score system for prognostic prediction of patients with non-small cell lung cancerJia-Yi Song, Xiao-Ping Li, Xiu-Jiao Qin, et al.Cancer Biomarkers : Section a of Disease Markers|August 25, 2020
The potential oncogenic role of the RAS-like GTP-binding gene RIT1 in glioblastomaAthar Khalil, Georges NemerCancer Biomarkers : Section a of Disease Markers|July 6, 2020
Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinomaModan Yang, Winyen Tan, Xinyu Yang, et al.Cancer Biomarkers : Section a of Disease Markers|July 6, 2020
Long intergenic noncoding RNA LINC00173 as a potential serum biomarker for diagnosis of non-small-cell lung cancerQian Yang, Shan Kong, Ming Zheng, et al.Cancer Biomarkers : Section a of Disease Markers|April 4, 2015
Expression of aberrant CD markers in acute leukemia: a study of 100 cases with immunophenotyping by multiparameter flowcytometryAnupam Sarma, Munlima Hazarika, Debabrata Das, et al.Cancer Biomarkers : Section a of Disease Markers|April 4, 2015
MMP-9/ANC score as a predictive biomarker for efficacy of bevacizumab plus platinum doublet chemotherapy in patients with advanced or recurrent non-squamous non-small cell lung cancerKazuya Hiura, Akiko Shiraishi, Chinami Suzuki, et al.Pageof 192